Brief: Clearpoint Neuro Announces FDA Clearance For Clearpoint Prism Neuro Laser Therapy System
Sept 23 (Reuters) - Clearpoint Neuro Inc CLPT.O :
* CLEARPOINT NEURO ANNOUNCES FDA CLEARANCE FOR CLEARPOINT
PRISM™
NEURO LASER THERAPY SYSTEM
Source text for Eikon: ID:nGNX5lkhyv
Further company coverage: CLPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028